secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptose Biosciences Inc. (APTOF)
CIK:        0000882361
Form:       8-K
Filed at:   2022-06-28T23:59:59+00:00
Accession:  0001171843-22-004578
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptose Biosciences appoints Fletcher Payne as SVP and CFO with $430k base salary and 1M option grant
--------------------------------------------------------------------------------

- Appointment effective June 27, 2022; Payne reports to CEO.
- Base salary of $430,000; eligible for annual discretionary bonus up to 40% of base.
- Subject to board approval, granted options to purchase 1,000,000 common shares.
- Severance: without cause or for good reason – one year salary lump sum, average bonus, COBRA up to 12 months.
- Payne previously CFO at Synapse, Catalyst Bioscience, CytomX, Plexxikon, and others.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882361/000117184322004578/0001171843-22-004578-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882361/000117184322004578/f8k_062822.htm
  HTML page:      https://secwatch.observer/filing/0001171843-22-004578

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer